10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 322 filers reported holding 10X GENOMICS INC in Q1 2021. The put-call ratio across all filers is 1.39 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,716,932 | +96.5% | 235,562 | +166.0% | 0.01% | +150.0% |
| Q2 2023 | $4,944,855 | +39471.5% | 88,554 | -60.5% | 0.00% | -71.4% |
| Q1 2023 | $12,496 | -71.7% | 223,981 | -81.5% | 0.01% | -70.8% |
| Q4 2022 | $44,216 | -99.3% | 1,213,394 | +467.3% | 0.02% | +500.0% |
| Q3 2022 | $6,092,000 | +54.5% | 213,907 | +145.5% | 0.00% | +100.0% |
| Q2 2022 | $3,942,000 | -73.3% | 87,116 | -55.2% | 0.00% | -75.0% |
| Q1 2022 | $14,782,000 | +41.0% | 194,316 | +176.0% | 0.01% | +60.0% |
| Q4 2021 | $10,487,000 | -63.1% | 70,402 | -55.1% | 0.01% | -75.0% |
| Q1 2021 | $28,394,000 | -40.9% | 156,873 | -53.8% | 0.02% | -42.9% |
| Q4 2020 | $48,068,000 | +611.0% | 339,463 | +526.0% | 0.04% | +337.5% |
| Q3 2020 | $6,761,000 | +19.4% | 54,225 | -40.3% | 0.01% | -38.5% |
| Q1 2020 | $5,664,000 | +196.1% | 90,888 | +262.3% | 0.01% | +550.0% |
| Q4 2019 | $1,913,000 | -21.7% | 25,086 | -48.3% | 0.00% | -50.0% |
| Q3 2019 | $2,444,000 | – | 48,506 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
| Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
| Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
| 12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
| FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
| JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
| Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
| Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
| HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
| RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |